n° 169 | January 2023
In this issue:

New technologies bring ability to transform cancer care

Europa Uomo backs new sustainable agenda
25 Jan 2023

EU's Cancer Plan 'at risk' if funding issue not resolved

Europa Uomo joins dozens of concerned cancer organisations
17 Jan 2023

New tool calculates each man's risk of prostate cancer

Data-based prediction could transform screening, say researchers
9 Jan 2023
Prostate research and treatments

Exercise can extend survival in advanced prostate cancer

Associations between increased volume and intensity of physical activity and reduced cancer-related mortality and disease progression have been reported in observational studies, providing a strong case for men with prostate cancer to engage in exercise.

Read the article from Cancerworld magazine here.

Prostatepedia's magazine on chemotherapy

The National Alliance of State Prostate Cancer Coalitions in the United States has produced a Prostatepedia issue fully devoted to chemotherapy for prostate cancer.

Europa Uomo News

EUPROMS 2.0 one-year follow-up questionnaire

Those people who responded to the EUPROMS 2.0 survey indicating that they would be interested in completing a follow-up survey after one year, please keep an eye on your mailbox in the coming weeks. This follow-up survey will be sent to you in the language in which you completed the EUPROMS 2.0 survey.

Items of Interest

Report of the European Cancer Summit 2022

During the European Cancer Summit 2022, held on 16th and 17th November, a Lancet Oncology Commission European Groundshot initiative was launched, with 12 evidence-based recommendations. They provide a roadmap to achieving a 70% average survival rate for all cancer patients in Europe by 2035.

Likewise, the European Cancer Pulse, also launched this year, is an innovative and interactive data visualisation tool tracking inequalities in cancer.

You can read the full report of the Summit 2022 here.

Oncologists encounter fear of cancer recurrence

Our own communications advisor, Simon Crompton, has written an article for Cancerworld entitled “What do you say when your patient can’t stop worrying about recurrence?” based on a survey which showed that cancer clinicians regularly encounter fear of cancer recurrence, but usually leave it to their patients to raise the subject.

Read the article here.

American prostate cancer webinar

AnCan, the Answer Cancer Foundation, is holding a free webinar entitled “Invasion of the Prostate Snatchers: 13 years later” on 30th January. Dr Mark Scholz” will be taking a look at how things have progressed in 13 years with prostate cancer, where they need to change, and where things are headed.

To register, click here.  If you can’t make the date, please register and you’ll be sent a link to the recording.


Survey for health app users

Label2Enable is a Horizon Europe project which aims to support the development and implementation of an EU quality label for health and wellness apps. It has launched a survey for European patients, informal caregivers and citizens, aiming to gain understanding of health app use, adoption, trust and preferences across the European Union.

The survey is anonymous, available in 26 languages, consists of 11 questions, and takes approximately five minutes to complete.

You can take the survey here.


All previous issues are available on website: www.europa-uomo.org/newsletters/